Callyope

Emerging

Clinical AI for mental health via speech analysis. Paris. AWS Pioneers 2026 cohort. $2.41M seed. 8 clinical trials ongoing. Founded 2023.

AI Mental Health Monitoring
Visit Website
Updated April 2026

Company Overview

Callyope (Paris) monitors brain health through speech-based AI. Foundation model trained on voice, language, clinical context, behavioral signals for depression, anxiety, insomnia, cognitive decline. $2.41M seed (360 Capital, Bpifrance). 8 clinical trials ongoing. AWS Pioneers 2026 European cohort.

Revenue
$2.41M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Callyope is an emerging player bringing innovative solutions to the Healthcare Tech market.

Frequently Asked Questions

Compare Callyope with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

Start Comparison →
For Callyope

Claim This Profile

Are you from Callyope? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Callyope Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Callyope vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →